| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator binding | 6.29e-05 | 140 | 31 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.92e-04 | 560 | 31 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.03e-04 | 566 | 31 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 4.81e-04 | 21 | 31 | 2 | GO:0061676 | |
| GeneOntologyMolecularFunction | transcription factor binding | 9.26e-04 | 753 | 31 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.11e-03 | 1412 | 31 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 1.93e-03 | 42 | 31 | 2 | GO:0051721 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.51e-03 | 1244 | 31 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 2.83e-03 | 1271 | 31 | 7 | GO:0000987 | |
| GeneOntologyBiologicalProcess | neuron development | GOLGA8B LHX2 VAX1 STRN ARID1B ZSWIM6 PBX1 MNX1 GOLGA8A MARCKS | 3.49e-05 | 1463 | 31 | 10 | GO:0048666 |
| GeneOntologyBiologicalProcess | epithelium development | 3.61e-05 | 1469 | 31 | 10 | GO:0060429 | |
| GeneOntologyBiologicalProcess | neuron projection development | 7.93e-05 | 1285 | 31 | 9 | GO:0031175 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.52e-04 | 802 | 31 | 7 | GO:0048812 | |
| GeneOntologyBiologicalProcess | tube development | 1.55e-04 | 1402 | 31 | 9 | GO:0035295 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.73e-04 | 819 | 31 | 7 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.82e-04 | 826 | 31 | 7 | GO:0048858 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 2.09e-04 | 77 | 31 | 3 | GO:0051289 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.77e-04 | 619 | 31 | 6 | GO:0002009 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.94e-04 | 1194 | 31 | 8 | GO:0000902 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 3.29e-04 | 18 | 31 | 2 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 3.68e-04 | 19 | 31 | 2 | GO:0060050 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 5.42e-04 | 23 | 31 | 2 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 5.91e-04 | 24 | 31 | 2 | GO:0060049 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | 6.33e-04 | 1014 | 31 | 7 | GO:0000278 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 6.44e-04 | 113 | 31 | 3 | GO:0051262 | |
| GeneOntologyBiologicalProcess | sensory organ development | 6.65e-04 | 730 | 31 | 6 | GO:0007423 | |
| GeneOntologyBiologicalProcess | regionalization | 6.76e-04 | 478 | 31 | 5 | GO:0003002 | |
| GeneOntologyBiologicalProcess | eye development | 6.89e-04 | 480 | 31 | 5 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 7.08e-04 | 483 | 31 | 5 | GO:0150063 | |
| GeneOntologyBiologicalProcess | Golgi localization | 7.50e-04 | 27 | 31 | 2 | GO:0051645 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 7.55e-04 | 748 | 31 | 6 | GO:0048667 | |
| GeneOntologyBiologicalProcess | sensory system development | 7.63e-04 | 491 | 31 | 5 | GO:0048880 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 7.66e-04 | 750 | 31 | 6 | GO:0048729 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 8.06e-04 | 28 | 31 | 2 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 8.06e-04 | 28 | 31 | 2 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 8.06e-04 | 28 | 31 | 2 | GO:0048313 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 8.12e-04 | 1390 | 31 | 8 | GO:0045944 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 9.45e-04 | 515 | 31 | 5 | GO:0050767 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.04e-03 | 526 | 31 | 5 | GO:0007389 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 1.08e-03 | 135 | 31 | 3 | GO:2000177 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 1.19e-03 | 34 | 31 | 2 | GO:0008356 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 1.33e-03 | 36 | 31 | 2 | GO:0010560 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 1.41e-03 | 37 | 31 | 2 | GO:0000212 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.44e-03 | 566 | 31 | 5 | GO:0007409 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | 1.50e-03 | 854 | 31 | 6 | GO:1903047 | |
| GeneOntologyCellularComponent | chromatin | 2.11e-04 | 1480 | 31 | 9 | GO:0000785 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 3.25e-04 | 1228 | 31 | 8 | GO:0036477 | |
| Domain | Homeobox_CS | 4.38e-07 | 186 | 30 | 6 | IPR017970 | |
| Domain | Homeobox | 1.67e-06 | 234 | 30 | 6 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.76e-06 | 236 | 30 | 6 | PS00027 | |
| Domain | HOX | 1.80e-06 | 237 | 30 | 6 | SM00389 | |
| Domain | Homeobox_dom | 1.89e-06 | 239 | 30 | 6 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.89e-06 | 239 | 30 | 6 | PS50071 | |
| Domain | - | 5.02e-06 | 283 | 30 | 6 | 1.10.10.60 | |
| Domain | Homeodomain-like | 1.25e-05 | 332 | 30 | 6 | IPR009057 | |
| Domain | GOLGA2L5 | 3.76e-04 | 18 | 30 | 2 | PF15070 | |
| Domain | Golgin_A | 3.76e-04 | 18 | 30 | 2 | IPR024858 | |
| Domain | EF_HAND_2 | 5.93e-03 | 231 | 30 | 3 | PS50222 | |
| Domain | EF_hand_dom | 6.00e-03 | 232 | 30 | 3 | IPR002048 | |
| Domain | - | 8.29e-03 | 261 | 30 | 3 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 1.07e-02 | 287 | 30 | 3 | IPR011992 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 10677249 | ||
| Pubmed | Identification and characterization of a novel Golgi protein, golgin-67. | 7.69e-07 | 2 | 31 | 2 | 10660574 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 9.69e-07 | 908 | 31 | 8 | 19274049 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 34510201 | ||
| Pubmed | 2.44e-06 | 709 | 31 | 7 | 22988430 | ||
| Pubmed | 3.77e-06 | 34 | 31 | 3 | 23926254 | ||
| Pubmed | 4.12e-06 | 35 | 31 | 3 | 39366759 | ||
| Pubmed | Ectopic Meis1 expression in the mouse limb bud alters P-D patterning in a Pbx1-independent manner. | 4.61e-06 | 4 | 31 | 2 | 19247936 | |
| Pubmed | A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition. | 4.88e-06 | 37 | 31 | 3 | 21725307 | |
| Pubmed | 6.11e-06 | 134 | 31 | 4 | 19030180 | ||
| Pubmed | 2.12e-05 | 60 | 31 | 3 | 18023262 | ||
| Pubmed | Hoxa2 downregulates Six2 in the neural crest-derived mesenchyme. | 2.15e-05 | 8 | 31 | 2 | 15634706 | |
| Pubmed | 3.26e-05 | 205 | 31 | 4 | 20436479 | ||
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 11069920 | ||
| Pubmed | Transcriptional mechanisms of EphA7 gene expression in the developing cerebral cortex. | 4.21e-05 | 11 | 31 | 2 | 21940705 | |
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 18547559 | ||
| Pubmed | 4.49e-05 | 77 | 31 | 3 | 21525287 | ||
| Pubmed | 5.05e-05 | 12 | 31 | 2 | 18519639 | ||
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 5.96e-05 | 13 | 31 | 2 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 5.96e-05 | 13 | 31 | 2 | 32873390 | |
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 21552007 | ||
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 5.96e-05 | 13 | 31 | 2 | 29128360 | |
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 5.96e-05 | 13 | 31 | 2 | 28055014 | |
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 5.96e-05 | 13 | 31 | 2 | 28028212 | |
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 30630895 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 6.95e-05 | 14 | 31 | 2 | 27226319 | |
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 26527010 | ||
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 37831422 | ||
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 6.95e-05 | 14 | 31 | 2 | 33543287 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 8.02e-05 | 15 | 31 | 2 | 17046993 | |
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 8.02e-05 | 15 | 31 | 2 | 26165940 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 8.02e-05 | 15 | 31 | 2 | 17189423 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 8.02e-05 | 15 | 31 | 2 | 17204322 | |
| Pubmed | 8.02e-05 | 15 | 31 | 2 | 26083584 | ||
| Pubmed | 8.02e-05 | 15 | 31 | 2 | 16413118 | ||
| Pubmed | 8.02e-05 | 15 | 31 | 2 | 37635409 | ||
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 8.02e-05 | 15 | 31 | 2 | 23185636 | |
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 8.02e-05 | 15 | 31 | 2 | 28509431 | |
| Pubmed | 8.56e-05 | 263 | 31 | 4 | 20932939 | ||
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 16399995 | ||
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 16336229 | ||
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 18166528 | ||
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 11784862 | ||
| Pubmed | Boc is a receptor for sonic hedgehog in the guidance of commissural axons. | 9.16e-05 | 16 | 31 | 2 | 17086203 | |
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 19109910 | ||
| Pubmed | Crossregulation between Neurogenin2 and pathways specifying neuronal identity in the spinal cord. | 9.16e-05 | 16 | 31 | 2 | 11502253 | |
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 9.16e-05 | 16 | 31 | 2 | 21640725 | |
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 1.04e-04 | 17 | 31 | 2 | 14718562 | |
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 27655914 | ||
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 14728599 | ||
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 22153077 | ||
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 28717168 | ||
| Pubmed | Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. | 1.04e-04 | 17 | 31 | 2 | 17322895 | |
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 20004763 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.12e-04 | 544 | 31 | 5 | 28473536 | |
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 21147753 | ||
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 15800058 | ||
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 24227724 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 1.17e-04 | 18 | 31 | 2 | 20230794 | |
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 22718342 | ||
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 1.17e-04 | 18 | 31 | 2 | 24367100 | |
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 20943658 | ||
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 25208654 | ||
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 23444373 | ||
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 12646573 | ||
| Pubmed | Stage-dependent function of Wnt5a during male external genitalia development. | 1.30e-04 | 19 | 31 | 2 | 34255394 | |
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 15452145 | ||
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 21539826 | ||
| Pubmed | Gdf11 facilitates temporal progression of neurogenesis in the developing spinal cord. | 1.30e-04 | 19 | 31 | 2 | 21248112 | |
| Pubmed | Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells. | 1.30e-04 | 19 | 31 | 2 | 14622145 | |
| Pubmed | CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development. | 1.30e-04 | 19 | 31 | 2 | 35705037 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 1.30e-04 | 19 | 31 | 2 | 17664336 | |
| Pubmed | Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration. | 1.30e-04 | 19 | 31 | 2 | 38048369 | |
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 17724343 | ||
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 22841714 | ||
| Pubmed | Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2. | 1.30e-04 | 19 | 31 | 2 | 17003038 | |
| Pubmed | Cell influx and contractile actomyosin force drive mammary bud growth and invagination. | 1.30e-04 | 19 | 31 | 2 | 34042944 | |
| Pubmed | Cdx and Hox genes differentially regulate posterior axial growth in mammalian embryos. | 1.45e-04 | 20 | 31 | 2 | 19853565 | |
| Pubmed | The COPI vesicle complex binds and moves with survival motor neuron within axons. | 1.45e-04 | 20 | 31 | 2 | 21300694 | |
| Pubmed | Intraflagellar transport molecules in ciliary and nonciliary cells of the retina. | 1.45e-04 | 20 | 31 | 2 | 20368623 | |
| Pubmed | 1.45e-04 | 20 | 31 | 2 | 23918928 | ||
| Pubmed | Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity. | 1.45e-04 | 20 | 31 | 2 | 31949138 | |
| Pubmed | Development of the post-natal growth plate requires intraflagellar transport proteins. | 1.45e-04 | 20 | 31 | 2 | 17359961 | |
| Pubmed | 1.45e-04 | 20 | 31 | 2 | 11071781 | ||
| Pubmed | The molecular complex of ciliary and golgin protein is crucial for skull development. | 1.45e-04 | 20 | 31 | 2 | 34128978 | |
| Pubmed | Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. | 1.45e-04 | 20 | 31 | 2 | 10482234 | |
| Pubmed | 1.45e-04 | 20 | 31 | 2 | 30236446 | ||
| Pubmed | Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability. | 1.45e-04 | 20 | 31 | 2 | 29437892 | |
| Pubmed | Rap2 function requires palmitoylation and recycling endosome localization. | 1.60e-04 | 21 | 31 | 2 | 19061864 | |
| Pubmed | 1.60e-04 | 21 | 31 | 2 | 15229288 | ||
| Pubmed | Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development. | 1.60e-04 | 21 | 31 | 2 | 27118846 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 1.60e-04 | 21 | 31 | 2 | 22216013 | |
| Pubmed | Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. | 1.60e-04 | 21 | 31 | 2 | 20003423 | |
| Pubmed | 1.60e-04 | 21 | 31 | 2 | 23386608 | ||
| Pubmed | 1.60e-04 | 21 | 31 | 2 | 21645620 | ||
| Pubmed | 1.60e-04 | 21 | 31 | 2 | 36292593 | ||
| Pubmed | 1.76e-04 | 22 | 31 | 2 | 8565076 | ||
| Pubmed | Control of craniofacial development by the collagen receptor, discoidin domain receptor 2. | 1.76e-04 | 22 | 31 | 2 | 36656123 | |
| Pubmed | A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. | 1.76e-04 | 22 | 31 | 2 | 10021340 | |
| Pubmed | 1.76e-04 | 22 | 31 | 2 | 34897463 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q14 | 7.88e-04 | 61 | 31 | 2 | chr15q14 | |
| Cytoband | 20q13.33 | 1.32e-03 | 79 | 31 | 2 | 20q13.33 | |
| GeneFamily | HOXL subclass homeoboxes | 1.81e-03 | 52 | 22 | 2 | 518 | |
| GeneFamily | EF-hand domain containing | 2.28e-03 | 219 | 22 | 3 | 863 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP | 3.47e-06 | 199 | 31 | 5 | M6978 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON | 2.34e-05 | 47 | 31 | 3 | M39019 | |
| Coexpression | BURTON_ADIPOGENESIS_11 | 3.00e-05 | 51 | 31 | 3 | MM1197 | |
| Coexpression | BURTON_ADIPOGENESIS_11 | 3.18e-05 | 52 | 31 | 3 | M1632 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 7.37e-05 | 191 | 31 | 4 | M40019 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP | 8.64e-05 | 199 | 31 | 4 | M9745 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.85e-05 | 279 | 31 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.51e-05 | 306 | 31 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.20e-06 | 166 | 31 | 4 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-06 | 189 | 31 | 4 | 7dad62bd50c197838058e89abd0ee387de3e83cd | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.87e-06 | 190 | 31 | 4 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.05e-06 | 191 | 31 | 4 | 4aa29337f4d2528577bb90dc4abfb6eab93e120f | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.05e-06 | 191 | 31 | 4 | 318323a12029a7992f16382cb0c186f5b2e1ca47 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-06 | 195 | 31 | 4 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 1.02e-05 | 197 | 31 | 4 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.04e-05 | 198 | 31 | 4 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.09e-05 | 200 | 31 | 4 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.09e-05 | 200 | 31 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 143 | 31 | 3 | 7adc34d8ad11e57950a5a258ae9bf8f52259385a | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 162 | 31 | 3 | 22f1abd20f43bc7e7fc46969da9962faf70ae5d2 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 162 | 31 | 3 | 966df4558140c3d541999ab553f201ae76a1c401 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-04 | 167 | 31 | 3 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 172 | 31 | 3 | 1bad7b19724e1b53ace7e05644215334c9f43910 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.32e-04 | 173 | 31 | 3 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 2.52e-04 | 178 | 31 | 3 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 183 | 31 | 3 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.74e-04 | 183 | 31 | 3 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 183 | 31 | 3 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 2.82e-04 | 185 | 31 | 3 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | IPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 2.82e-04 | 185 | 31 | 3 | 77fbecdab10bacc005b1c7e22ca414cfecef13c1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 186 | 31 | 3 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-04 | 186 | 31 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 3.01e-04 | 189 | 31 | 3 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 189 | 31 | 3 | d00410010283dc6191ce9857d6c7952678fed588 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 189 | 31 | 3 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.05e-04 | 190 | 31 | 3 | 13dc3a0aaa554f63eabac37726bd1f11b66fb3dd | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.05e-04 | 190 | 31 | 3 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.10e-04 | 191 | 31 | 3 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4|Lung / Manually curated celltypes from each tissue | 3.15e-04 | 192 | 31 | 3 | fd19cd0b5330448bef8debd753285adbc8b958a2 | |
| ToppCell | wk_15-18-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.15e-04 | 192 | 31 | 3 | ab54d4bfc61ef7e3d765afe6e4a6d7011a301ecd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.15e-04 | 192 | 31 | 3 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-04 | 192 | 31 | 3 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 192 | 31 | 3 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.20e-04 | 193 | 31 | 3 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Control-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.20e-04 | 193 | 31 | 3 | 2c1fce66ad688f2ec0278fc86afaa1bf107bb9f4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.20e-04 | 193 | 31 | 3 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | facs-Marrow-B-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 193 | 31 | 3 | 24c34c6635eb7fc2878282803c421b64320e77d8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.25e-04 | 194 | 31 | 3 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | ad1aacff97beb76f4211942676e1d5e84087d44e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.25e-04 | 194 | 31 | 3 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | fdd59b1e036b2d6d8877e1a920a0e56a91a2a882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.25e-04 | 194 | 31 | 3 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.30e-04 | 195 | 31 | 3 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.30e-04 | 195 | 31 | 3 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.30e-04 | 195 | 31 | 3 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Trm_Th1/Th17|Liver / Manually curated celltypes from each tissue | 3.30e-04 | 195 | 31 | 3 | 480cc62ee1e5b1aaf6b62be6e5afd7a81236a1b0 | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.30e-04 | 195 | 31 | 3 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 196 | 31 | 3 | 27a216af92100224818c91e298428bee25ab0af8 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 3.34e-04 | 196 | 31 | 3 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | facs-Skin-nan-18m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 196 | 31 | 3 | 81f9754567bbfa67edd304b9ef7b03e7bd9a3b52 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.34e-04 | 196 | 31 | 3 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.34e-04 | 196 | 31 | 3 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.34e-04 | 196 | 31 | 3 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.34e-04 | 196 | 31 | 3 | 45d1c0a962c4221c17393ee5566961d1deebf442 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-04 | 196 | 31 | 3 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.34e-04 | 196 | 31 | 3 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | T_cells-CCR7+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.40e-04 | 197 | 31 | 3 | 904430779c42b51d3eec62cf0cdd501b17058d8b | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.40e-04 | 197 | 31 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-04 | 197 | 31 | 3 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-04 | 197 | 31 | 3 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.40e-04 | 197 | 31 | 3 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.40e-04 | 197 | 31 | 3 | cf72160f03105876641fa6fdc7405e339eb084c7 | |
| ToppCell | severe-Myeloid-Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.45e-04 | 198 | 31 | 3 | 636878836678a0715550fa09f2e3dac11c4d73fe | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.45e-04 | 198 | 31 | 3 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.45e-04 | 198 | 31 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 198 | 31 | 3 | 8d7eb43b3e3b4a15265985143991e42afc20dc85 | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 3.45e-04 | 198 | 31 | 3 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.45e-04 | 198 | 31 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 3.45e-04 | 198 | 31 | 3 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 3.45e-04 | 198 | 31 | 3 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.50e-04 | 199 | 31 | 3 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.50e-04 | 199 | 31 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.50e-04 | 199 | 31 | 3 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | 21-Trachea-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 3.50e-04 | 199 | 31 | 3 | 8eb8b086c38960200578a9fe8853ca6e894ddee4 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.50e-04 | 199 | 31 | 3 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.50e-04 | 199 | 31 | 3 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Sigmoid-T_cell-Th1|T_cell / Region, Cell class and subclass | 3.55e-04 | 200 | 31 | 3 | bc9433a8ec3a6f10816730a32b821c63d78e6e87 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.55e-04 | 200 | 31 | 3 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | 3d51aebf626dd4656ab4aac8a20d761b8062c42d | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 3.55e-04 | 200 | 31 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | COVID|World / Condition, Cell_class and T cell subcluster | 3.55e-04 | 200 | 31 | 3 | 04a932fe2431e7886120c219ce666f90d3030a1c | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 5.47e-06 | 190 | 31 | 5 | 2721_UP | |
| Drug | SC 19220; Up 200; 10uM; PC3; HT_HG-U133A | 6.05e-06 | 194 | 31 | 5 | 7065_UP | |
| Disease | sleep efficiency | 9.31e-06 | 5 | 29 | 2 | EFO_0803364 | |
| Disease | sucrose liking measurement | 1.75e-04 | 20 | 29 | 2 | EFO_0010157 | |
| Disease | visual epilepsy (implicated_via_orthology) | 5.13e-04 | 34 | 29 | 2 | DOID:11832 (implicated_via_orthology) | |
| Disease | sitting height ratio | 1.15e-03 | 51 | 29 | 2 | EFO_0007118 | |
| Disease | neurofilament light chain measurement | 1.44e-03 | 57 | 29 | 2 | EFO_0009178 | |
| Disease | FEV change measurement, response to bronchodilator | 1.49e-03 | 58 | 29 | 2 | EFO_0005921, GO_0097366 | |
| Disease | monocyte count | 1.55e-03 | 1320 | 29 | 6 | EFO_0005091 | |
| Disease | Epilepsy, Cryptogenic | 2.95e-03 | 82 | 29 | 2 | C0086237 | |
| Disease | Awakening Epilepsy | 2.95e-03 | 82 | 29 | 2 | C0751111 | |
| Disease | Aura | 2.95e-03 | 82 | 29 | 2 | C0236018 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAGAGAVAAAAAAAA | 416 | Q8NFD5 | |
| AAAGAAAGGQQAAAG | 541 | Q8NFD5 | |
| GGGGGAAAAAAAACR | 86 | Q6P1R3 | |
| SAAAAAAAAASGGAG | 126 | P40424 | |
| HAGGALGNAACIGFA | 61 | Q7Z3Y7 | |
| GAGALAAAGAAGAAA | 26 | Q9UBI9 | |
| AAAGAAGAAAGGALA | 31 | Q9UBI9 | |
| AGAAAGGALAAAAGC | 36 | Q9UBI9 | |
| GGALAAAAGCGAAAA | 41 | Q9UBI9 | |
| AAAGCGAAAAGAPGA | 46 | Q9UBI9 | |
| AGGAGTGAANAAAAA | 66 | Q9UBI9 | |
| AAAAAAAAAGGLALG | 126 | P50219 | |
| GAAAAAAAAAAGGPS | 156 | P17535 | |
| LAAAAAAGGGASGAG | 16 | Q9Y6V0 | |
| AAAAAAKSAGLGAAG | 191 | P50458 | |
| AAAAAAATGGLCGDF | 96 | Q12778 | |
| AAAAAAAAAAAGVGG | 31 | O95390 | |
| RAAGAAGAAAAAASG | 26 | Q9NS18 | |
| AAGGAAAAAAEAGAA | 196 | P29966 | |
| NASGALAGEAAAAGG | 11 | Q9Y5N1 | |
| EAAGAAGDGVAACGS | 486 | A8MQT2 | |
| PGACAAGAAAAAGVE | 1036 | Q9BYK8 | |
| GCAAAAAAGAPAGGA | 136 | Q5T953 | |
| AGAAGDGVAACGSYS | 516 | A7E2F4 | |
| AAAGDGAAAAGAARA | 31 | O43815 | |
| ACFGGAGGQHACAIA | 486 | O14841 | |
| AAAVAGAALAGAGAA | 36 | Q8IYU8 | |
| AAAAAGAGAGAAAAG | 46 | Q8N196 | |
| AAAAAAAAAAAGAGG | 41 | P31271 | |
| AAAAAAAAAAAAGGG | 6 | Q8NFH8 | |
| VAAAGAAAGAAAGAA | 66 | Q5BIV9 | |
| AAAGAAAGAAAGLAA | 71 | Q5BIV9 | |
| AAAAAAAGAGAGAKQ | 101 | P55011 | |
| AGCAAVGASLAAPGG | 31 | Q13563 | |
| CAGGGAACASAAAEA | 6 | Q9H2K2 | |
| AAAAAACGGGAALGL | 51 | Q9HCJ5 | |
| CEFLLAGAGGAGAGA | 71 | Q7Z7E8 | |
| ALGAGAAAGSAAAAA | 216 | Q5SQQ9 |